Elmet is trying to turn its existing tungsten manufacturing base into a vertically integrated U.S. supply chain, including a majority-owned joint venture to restart Blue Moon’s dormant Springer ammonium paratungstate plant. That broader project was already disclosed as part of a $150 million Elmet investment framework and a planned 70%-owned JV.
This filing converts a known commitment into a formal security issuance. Elmet issued Blue Moon a warrant for up to 1,166,970 common shares. 〔0〕 The letter agreement had already contemplated warrants with a three-year term and six-month exercise lockout, so the main new information is the finalized share count and strike price—not a surprise change in strategy.
The warrant does not provide Elmet with cash today. The agreement states that “no separate cash purchase price or other consideration shall be payable” for the warrant. 〔1〕 The consideration is Blue Moon’s entry into the broader letter agreement and its obligations, including the planned investment and Springer partnership.
The economic cost is future dilution, not immediate financing. The warrant carries a $21.423 exercise price. It cannot be exercised for six months and expires three years after issuance. 〔2〕 Until exercise, no shares are issued and no exercise proceeds are received; if exercised, Elmet would issue up to 1.17 million shares.
Bottom line: This is execution of an already disclosed Springer transaction, not a new source of capital. It modestly advances the partnership’s documentation while leaving the bigger value question—whether the mine and APT plant actually get funded, built, and restarted—to the remaining definitive agreements and project milestones.
Read the original 8-K on SEC EDGAR ↗